Skip to main content
. 2025 Aug 25;26(17):8227. doi: 10.3390/ijms26178227
ACPA Anti-Citrullinated Peptide Antibody
ACS Acute Coronary Syndrome
AD Alzheimer’s Disease
ADNI Alzheimer’s Disease Neuroimaging Initiative
Beta-Amyloid (Amyloid-beta)
Aβ42 Amyloid-beta 1–42
Abeta40 Amyloid-beta 1–40
Anti-CCP Anti-Cyclic Citrullinated Peptide
Anti-Hsp60 Antibodies Against 60 kDa Heat Shock Protein
BDI-II Beck Depression Inventory-II
BMI Body Mass Index
BNP B-Type Natriuretic Peptide
BRASS Brigham and Women’s Rheumatoid Arthritis Sequential Study
C Complement System
CAD Coronary Artery Disease
CD Cluster of Differentiation
CHD Coronary Heart Disease
CIA Collagen-Induced Arthritis
CMD Coronary Microvascular Dysfunction
CRP C-Reactive Protein
csDMARDs Conventional Synthetic Disease-Modifying Antirheumatic Drugs
CV Cardiovascular
CVD Cardiovascular Disease
DAS28-CRP Disease Activity Score 28 (or in 28 joints)-CRP
DBS Dried Blood Spot
DMARDs Disease-Modifying Anti-Rheumatic Drugs
EC Endothelial Cell
ECG Electrocardiogram
ELISA Enzyme-Linked Immunosorbent Assay
ESR Erythrocyte Sedimentation Rate
EV/EVs Extracellular Vesicles
Fcγ receptors Fc gamma receptors
FLS Fibroblast-like Synoviocytes
HDL High-Density Lipoprotein
hscTnT High-Sensitivity Cardiac Troponin T
hsCRP High-Sensitivity C-Reactive Protein
IFN-γ Interferon-gamma
IL-1β Interleukin-1 beta
IL-2 Interleukin-2
IL-6 Interleukin-6
IL-12 Interleukin-12
IL-18 Interleukin-18
IL-33 Interleukin-33
IMT Intima-Media Thickness
JAKi Janus Kinase Inhibitor
LDL-C Low-Density Lipoprotein Cholesterol
LPS Lipopolysaccharide
LpPLA2 Lipoprotein-Associated Phospholipase A2
MAPK Mitogen-Activated Protein Kinase
MAC Membrane Attack Complex
MACE Major Adverse Cardiac Events
MCP-1 Monocyte Chemoattractant Protein-1
MDD Major Depressive Disorder
MetS Metabolic Syndrome
MFR Myocardial Flow Reserve
MHC-II Major Histocompatibility Complex Class II
MRI Magnetic Resonance Imaging
MPs Microparticles
mCRP Monomeric C-Reactive Protein
MVs Microvesicles
nCRP Native (Pentameric) C-Reactive Protein
NK Natural Killer Cells
NF-κB Nuclear Factor Kappa-light-chain-enhancer of Activated B cells
NFTs Neurofibrillary Tangles
NHIRD National Health Insurance Research Database (Taiwan)
OA Osteoarthritis
OPN Osteopontin
PAD Peripheral Artery Disease
PC Phosphocholine
PE Phosphoethanolamine
PET Positron Emission Tomography
PHCs Progenitor Hematopoietic Cells (CD34+ cells)
PHQ-9 Patient Health Questionnaire-9
pCRP/pCRP* Pentameric C-Reactive Protein/Pentameric Symmetrical CRP (with neoepitope exposed)/Conformational Intermediate of CRP
PWV Pulse Wave Velocity
RA Rheumatoid Arthritis
RAGE/RAGEs Receptor for Advanced Glycation End Products
RF Rheumatoid Factor
ROS Reactive Oxygen Species
sPLA2 Secretory Phospholipase A2
sRAGE Soluble Receptor for Advanced Glycation End Products
SA Stable Angina
S100A8/A9 Calprotectin
SLE Systemic Lupus Erythematosus
SSc Systemic Sclerosis
SPs Senile Plaques
ST2 Suppression of Tumorigenicity 2 (soluble form often denoted as sST2)
STCS Speckle Tracking Carotid Strain
suPAR Soluble Urokinase Plasminogen Activator Receptor
TNF Tumor Necrosis Factor
TNF-α Tumor Necrosis Factor Alpha
TGF-β Transforming Growth Factor Beta
VAS Visual Analog Scale
VEGF Vascular Endothelial Growth Factor